Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study

Approximately one-third of patients on biologic therapy for rheumatoid arthritis (RA) receive them as monotherapy. There are few head-to-head randomised control trials comparing biologics as monotherapy. Our aim was to compare the efficacy and persistence of multimodal biologic agents as monotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Benson, Rosalind, Zhao, Sizheng Steven, Goodson, Nicola, Abernethy, Rikki, Mewar, Devesh, Barnes, Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256103/
https://www.ncbi.nlm.nih.gov/pubmed/32086605
http://dx.doi.org/10.1007/s00296-020-04531-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256103/
https://www.ncbi.nlm.nih.gov/pubmed/32086605
http://dx.doi.org/10.1007/s00296-020-04531-6

Ejemplares similares